Cargando…
The conservative view: is it necessary to implant a stent into the dopamine transporter?
This article is a reply to De Felice LJ and Cameron KN (2015). Comments on ‘A quantitative model of amphetamine action on the serotonin transporter’, by Sandtner et al., Br J Pharmacol 171: 1007–1018. Br J Pharmacol 172: this issue, doi: 10.1111/bph.12767, commenting on Sandtner W, Schmid D, Schicke...
Autores principales: | Schmid, D, Koenig, X, Bulusu, S, Schicker, K, Freissmuth, M, Sitte, H H, Sandtner, W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4561504/ https://www.ncbi.nlm.nih.gov/pubmed/24824446 http://dx.doi.org/10.1111/bph.12766 |
Ejemplares similares
-
Dual Action of Zn(2+) on the Transport Cycle of the Dopamine Transporter
por: Li, Yang, et al.
Publicado: (2015) -
Occupancy of the Zinc-binding Site by Transition Metals Decreases the Substrate Affinity of the Human Dopamine Transporter by an Allosteric Mechanism
por: Li, Yang, et al.
Publicado: (2017) -
A quantitative model of amphetamine action on the 5-HT transporter
por: Sandtner, Walter, et al.
Publicado: (2014) -
The Mechanistic Basis for Noncompetitive Ibogaine Inhibition of Serotonin and Dopamine Transporters
por: Bulling, Simon, et al.
Publicado: (2012) -
Handling of intracellular K(+) determines voltage dependence of plasmalemmal monoamine transporter function
por: Bhat, Shreyas, et al.
Publicado: (2021)